Announced Sat, 2 Aug · 11:12 IST

Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Unaudited ....

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lotus Eye Hospital and Institute Ltd has informed the stock exchanges that its Board of Directors will meet on Tuesday, August 12, 2025 at 4:00 PM. The main agenda is to consider and approve the Unaudited Standalone Financial Results for the quarter and period ended June 30, 2025 (Q1 FY26). This is a routine regulatory filing under SEBI LODR Regulation 29. The company also announced that the insider trading window will re-open from August 15, 2025, after being closed ahead of the results.

Likely market impact

This is a procedural filing with no direct impact on the stock. Investors should watch for the actual Q1 FY26 results on August 12, 2025, which will provide the first insight into the company's financial performance for the new fiscal year.